Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer

HIGHLIGHTS

• who: Tommaso Cornali from the DepartmentSapienza University of Rome, Rome, Italy have published the research: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer, in the Journal: (JOURNAL) of 31/Dec/2016
• what: These investigators reported a complete cytoreduction rate analogous to that in the series , but achieved higher overall survival rates also if the median PCI and median follow-up period were less than the rates the authors report (median PCI, 12 vs. 15; median follow-up period, 19.4 vs. 73 months).
• how: The authors conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.